ACTN4 and cancer: Aberrant actinin‐4 expression has been implicated in the development and progression of various malignancies, including lung, breast, and colorectal cancers, where it has been associated with increased cell motilities and cancer invasion, often correlating with a less favorable patient prognosis [8, 9, 10, 11].